Mankind Pharma gets GST penalty order of about Rs 15.32 crore

Regulatory & Legal View source PDF Explain this filing

MANKIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.0%Reaction day

₹2146.00

prior close

₹2148.90

announcement price

After-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+0.9%+0.1% vs market

Pharmaceuticals peers, median of 156sector+0.6%+0.4% vs sector

On the reaction day the stock moved 0.1 pts more than Nifty Midcap 150 and 0.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.5

10m

-0.2

15m

+0.0

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.0+0.9+0.1+0.6+0.4

Next day

+1.2+2.0-0.9+1.0+0.1

+0.1+2.0-1.9+0.6-0.5

-1.8+1.2-3.0+0.1-1.9

-1.6+0.6-2.2-0.7-0.9

-0.5+0.9-1.4-0.6+0.1

+1.8+2.9-1.0+0.8+1.0

15d

+2.6+4.0-1.4+1.6+1.0

+3.2+1.1+2.1-1.9+5.1

-2.8+3.0-5.8-2.1-0.7

+4.1-4.0+8.1-6.5+10.6

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mankind Pharma received a GST order from the Joint Commissioner, CGST and Central Excise, Patna on December 10, 2025, levying a penalty of about Rs 15.32 crore for the period FY 2018-19 to 2022-23 over disallowance of input tax credit due to reconciliation differences in GST returns. The company says the order is not tenable in law and plans to file an appeal. Management states there is no material impact on financials, operations, or other activities.

Likely market impact

Company will appeal the order; management says no material financial or operational impact expected.